Zu-Yau Lin

6PUBLICATIONS
13CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer geneticsRespiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 27, 2025
Phase IIb Trial for the Palliative Treatment of Patients With Primary Hepatic Malignancy Unable to Receive Curative Treatment: Efficacy of Colchicine.

Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang

|Dec 31, 2024
Safety of transarterial chemoembolization on renal function in combined hepatocellular carcinoma and chronic kidney disease patients.

Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang

|Oct 28, 2023
Dose Consideration of Lenvatinib's Anti-Cancer Effect on Hepatocellular Carcinoma and the Potential Benefit of Combined Colchicine Therapy.

Zu-Yau Lin, Ming-Lun Yeh, Po-Cheng Liang

|Feb 10, 2022
Limited sorafenib anticancer effects on primary cultured hepatocellular carcinoma cells with high NANOG expression.

Zu-Yau Lin, Ming-Lun Yeh, Ching-I Huang

|Oct 23, 2021
The Persistence of Hepatitis C Virus Infection in Hepatocytes Promotes Hepatocellular Carcinoma Progression by Pro-Inflammatory Interluekin-8 Expression.

Ciniso Sylvester Shabangu, Phumelele Yvonne Siphepho, Chia-Yang Li

|Feb 03, 2021
Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.

Yu-Ju Wei, Po-Yao Hsu, Jia-Jung Lee

Pageof 1

Frequent Collaborators

4 joint publications

Chia-Yen Dai

4 joint publications

Ming-Lung Yu

3 joint publications

Chung-Feng Huang

2 joint publications

Po-Cheng Liang